We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
In the recent past, many, globally and in India, had raised concerns about a potential shortage of ancillary supplies to distribute the vaccine, after development.